Citadel Advisors
MTEM

Citadel Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Citadel Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,362
Closed -$114K – 13988
2022
Q2 		$114K Buy
8,362
+7,393
+763% +$173K ﹤0.01% 11291
2022
Q1 		$50K Buy
+969
New +$42.8K ﹤0.01% 12790
2021
Q2 		– Sell
-926
Closed -$121K – 14695
2021
Q1 		$175K Sell
926
-3,957
-81% -$694K ﹤0.01% 11870
2020
Q4 		$688K Buy
4,883
+807
+20% +$119K ﹤0.01% 7535
2020
Q3 		$668K Buy
4,076
+1,231
+43% +$219K ﹤0.01% 6778
2020
Q2 		$589K Buy
+2,845
New +$661K ﹤0.01% 6781
2019
Q3 		– Sell
-886
Closed -$111K – 9925
2019
Q2 		$111K Buy
+886
New +$96.3K ﹤0.01% 8504
2019
Q1 		– Sell
-709
Closed -$43K – 10062
2018
Q4 		$43K Buy
+709
New +$49.5K ﹤0.01% 8527
2017
Q4 		– Sell
-776
Closed -$81K – 8578
2017
Q3 		$81K Buy
+776
New +$67K ﹤0.01% 7090
2016
Q4 		– Sell
-1,736
Closed -$194K – 8019
2016
Q3 		$194K Buy
1,736
+921
+113% +$127K ﹤0.01% 6329
2016
Q2 		$85K Buy
815
+620
+318% +$44.4K ﹤0.01% 6261
2016
Q1 		$15K Buy
195
+26
+15% +$1.53K ﹤0.01% 6550
2015
Q4 		$13K Sell
169
-874
-84% -$431K ﹤0.01% 8185
2015
Q3 		$701K Buy
1,043
+858
+464% +$610K ﹤0.01% 4303
2015
Q2 		$124K Sell
185
-823
-82% -$544K ﹤0.01% 6867
2015
Q1 		$675K Buy
1,008
+550
+120% +$362K ﹤0.01% 4480
2014
Q4 		$241K Sell
458
-254
-36% -$127K ﹤0.01% 5747
2014
Q3 		$424K Buy
712
+440
+162% +$304K ﹤0.01% 4837
2014
Q2 		$177K Buy
272
+83
+44% +$55K ﹤0.01% 5692
2014
Q1 		$149K Sell
189
-94
-33% -$76.3K ﹤0.01% 5804
2013
Q4 		$218K Buy
283
+254
+876% +$192K ﹤0.01% 4941
2013
Q3 		$22K Sell
29
-189
-87% -$155K ﹤0.01% 6170
2013
Q2 		$189K Buy
+218
New +$184K ﹤0.01% 4724

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors's MTEM Position: Q3 2022 in Review

Citadel Advisors sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 8,362 shares — an estimated $114K sold.

Citadel Advisors first reported a position in MTEM in Q2 2013 and held it in 23 quarters. The position peaked at $701K in Q3 2015. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

  • Citadel Advisors reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 8,362 Molecular Templates, Inc. shares in Q3 2022, an estimated $114K.
  • Citadel Advisors first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 23 quarters.
  • Citadel Advisors's Molecular Templates, Inc. position peaked at $701K in Q3 2015.
  • 58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.